Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments-Reference-Cited by-同舟云学术

Characterization of ascending dose canine telemetry model supports its use in E14/S7B QT integrated risk assessments

Published:2024-07 Issue: Volume:128 Page:107525
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Chaves Alysia A.,Ferraro Jude W.,Yu Jing,Moye Matthew J.,Yee Ka Lai,Li Fangbiao,Steve Desiree L.,Lengel David J.,Regan Christopher P.

Publisher

Elsevier BV

Reference17 articles.

1. The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing;Allen;British Journal of Clinical Pharmacology,2000

2. E14 and S7B clinical and nonclinical evaluation of QT / QTc interval prolongation and Proarrhythmic potential — Questions and answers guidance for industry E14 and S7B clinical and nonclinical evaluation of QT / QTc interval prolongation and Proarrhythmic;Anonymous,2022

3. E14/S7B Q&A training material;Anonymous,2022

4. A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and MK-499;Chaves;Journal of Pharmacological and Toxicological Methods,2007

5. Evaluation of moxifloxacin in canine and non-human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration-QTc analysis;Chui;Clinical and Translational Science,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches to cardiovascular safety pharmacology assessment;Journal of Pharmacological and Toxicological Methods;2024-07